Taken together, these results suggest that CPE and CFSE administration could ameliorate obesity and related metabolic disorders in HF diet-induced obesity mice probably through the inhibition of PPARγ and LXRs gene expressions. The gene discussed is PPARG; the disease is obesity due to melanocortin 4 receptor deficiency.